SBIO Holdings Information

SBIO is an equity ETF with a total of 89 individual holdings. The top holdings are Kymera Therapeutics stock at 4.66%, Celcuity at 3.34%, Alkermes at 3.21%, CG Oncology at 3.06%, and Mirum Pharmaceuticals at 3.06%.

Total Holdings

Top 10 Percentage

30.47%

Asset Class

Equity

ETF Category

Health

Assets

138.03M

PE Ratio

n/a

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	KYMR	Kymera Therapeutics, Inc.	4.66%	70,365
2	CELC	Celcuity Inc.	3.34%	41,241
3	ALKS	Alkermes plc	3.21%	147,168
4	CGON	CG Oncology, Inc.	3.06%	71,897
5	MIRM	Mirum Pharmaceuticals, Inc.	3.06%	45,804
6	FOLD	Amicus Therapeutics, Inc.	2.86%	274,988
7	ACAD	ACADIA Pharmaceuticals Inc.	2.68%	150,789
8	NAMS	NewAmsterdam Pharma Company N.V.	2.60%	101,063
9	CRNX	Crinetics Pharmaceuticals, Inc.	2.52%	84,576
10	APGE	Apogee Therapeutics, Inc.	2.48%	48,872
11	VKTX	Viking Therapeutics, Inc.	2.47%	100,746
12	GPCR	Structure Therapeutics Inc.	2.47%	54,083
13	XENE	Xenon Pharmaceuticals Inc.	2.16%	68,873
14	SYRE	Spyre Therapeutics, Inc.	2.15%	69,157
15	EWTX	Edgewise Therapeutics, Inc.	2.08%	94,360
16	TARS	Tarsus Pharmaceuticals, Inc.	2.07%	37,835
17	DNLI	Denali Therapeutics Inc.	2.01%	131,033
18	IDYA	IDEAYA Biosciences, Inc.	1.82%	78,135
19	TVTX	Travere Therapeutics, Inc.	1.72%	79,744
20	APLS	Apellis Pharmaceuticals, Inc.	1.71%	112,768
21	VERA	Vera Therapeutics, Inc.	1.68%	56,977
22	IRON	Disc Medicine, Inc.	1.62%	33,646
23	DNTH	Dianthus Therapeutics, Inc.	1.53%	38,214
24	MLYS	Mineralys Therapeutics, Inc.	1.50%	70,537
25	GLPG	Galapagos NV	1.42%	58,387

Showing 25 of 89 holdings

Subscribe to see the full list

Activate Now

As of Feb 27, 2026